Exodus Movement, Inc. (OTCQX: EXOD), (the "Company" or "Exodus") the leading self-custodial cryptocurrency software platform, today announced its results ...
Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer's; on track to generate top-line data H1 2025 - - Recent third-party clinical data esta ...